multiplex assay genmark eplex respiratory pathogen panel (rpp) (GenMark Diagnostics)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

GenMark Diagnostics multiplex assay genmark eplex respiratory pathogen panel (rpp)
Multiplex Assay Genmark Eplex Respiratory Pathogen Panel (Rpp), supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex+rpp/eplex+respiratory+pathogen+panel/pmc12268109-151-15-18
Average 90 stars, based on 1 article reviews

multiplex assay genmark eplex respiratory pathogen panel (rpp) - by Bioz Stars, 2026-09

90/100 stars

Images

Transmission Electron Microscopy:

Article Title: Molecular Diagnostic Advances in Transplant Infectious Diseases.
Article Snippet: Purpose of Review The infectious complications of transplantation can have devastating consequences for patients.. Early and accurate diagnosis is essential to good outcomes.. This review describes recent advances in pathogen-directed diagnostic testing and discusses the role of new methods for transplant infectious diseases.

AST Assay:

Bacteria:

other:

Article Title: Comparison between Nasopharyngeal and Saliva Samples for the Detection of Respiratory Viruses in Children with Acute Lower Respiratory Tract Infections: A Pilot Study
Article Snippet: Pathogen detection was performed using QIAstat-Dx Respiratory SARS-CoV-2 Panel (Qiagen, Hilden, Germany), the ePlex ® Respiratory Pathogen Panel (ePlex RPP) by GenMark Diagnostics, Inc. (Carlsbad, CA, USA), and the Aptima SARS-CoV-2 assay on the Panther instrument (Hologic, Inc., San Diego, CA, USA).

Multiplex Assay:

Article Title: Clinical microbiology
Article Snippet: .. Several multiplex panels designed to detect respiratory pathogens have been FDA-cleared, including more traditional assays such as Luminex xTAG Respiratory Viral Panel (RVP; Luminex Corporation), the Luminex xTAG RVP Fast (Luminex Corporation), and the Luminex xTAG Respiratory Pathogen Panel (RPP; Luminex Corporation); newer sample-to-answer assays such as FilmArray Respiratory Panel (RP; BioFire Diagnostics) and RP2; Verigene Respiratory Pathogens Flex test (Luminex Corporation); and ePlex RPP (GenMark Diagnostics). ..

Article Title: Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens
Article Snippet: .. Previous studies evaluating the diagnostic performance of the QIAstat‐Dx‐RP2.0 compared to other currently available multiplex panel testing systems include a multicenter, retrospective analysis of 287 clinical respiratory specimens using the Genmark ePlex Respiratory Pathogen Panel (ePlex RPP) [ ], a single‐center, retrospective comparison of 65 clinical respiratory specimens using the ePlex RPP and BioFire‐RP2.1 [ ], and a single‐center, retrospective comparison involving 137 patient nasopharyngeal swabs with the BioFire‐RP2.1 [ ]. .. The findings from these studies align with the results of our study, demonstrating good diagnostic performance of the QIAstat‐Dx‐RP2.0, with high positive agreement rates of 92%–94% with the ePlex RPP [ , ], and 82% with the BioFire‐RP2.1 [ ].

Article Title: Multicenter Evaluation of the QIAstat-Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens.
Article Snippet: .. Previous studies evaluating the diagnostic performance of the QIAstat‐Dx‐RP2.0 compared to other currently available multiplex panel testing systems include a multicenter, retrospective analysis of 287 clinical respiratory specimens using the Genmark ePlex Respiratory Pathogen Panel (ePlex RPP) [11], a single‐center, retrospective comparison of 65 clinical respiratory specimens using the ePlex RPP and BioFire‐RP2.1 [29], and a single‐center, retrospective comparison involving 137 patient nasopharyngeal swabs with the BioFire‐RP2.1 [12]. .. The findings from these studies align with the results of our study, demonstrating good diagnostic performance of the QIAstat‐Dx‐ RP2.0, with high positive agreement rates of 92%–94% with the ePlex RPP [11, 29], and 82% with the BioFire‐RP2.1 [12].

Diagnostic Assay:

Comparison:

Real-time Polymerase Chain Reaction:

Article Title: Point-of-care molecular diagnosis of Mycoplasma pneumoniae including macrolide sensitivity using quenching probe polymerase chain reaction
Article Snippet: 1 , FilmArray RP2plus (Biofire) , QPCR , CARDS toxin , NPS , No , Yes , 45min , 30 CFU/mL for strain M129 , 254(W) × 393(D) × 165(H), 18kg , 23, 24. .. 2 , ePlex RPP (GenMark) , QPCR , P1 adhesin , NPS , No , Yes , 120min , 300 CCU/mL for strain M129 , 480(W) x 540(D) x 590(H), 40kg , 25. .. 3 , NxTAG RPP (Luminex) , QPCR , P1 adhesin , NPS , No , No , 240min , 142 CCU/mL , 165(W) x 600(D) x 430(H), 18kg , 14, 26, 27.

Review